Aliases & Classifications for Skin Conditions

Aliases & Descriptions for Skin Conditions:

Name: Skin Conditions 38 41
Dermatologic Disorders 69

Classifications:



Summaries for Skin Conditions

MedlinePlus : 41 your skin is your body's largest organ. it covers and protects your body. your skin holds body fluids in, preventing dehydration keeps harmful microbes out, preventing infections helps you feel things like heat, cold, and pain keeps your body temperature even makes vitamin d when the sun shines on it anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. many skin problems, such as acne, also affect your appearance. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Skin Conditions, also known as dermatologic disorders, is related to darier disease and ichthyosis with confetti, and has symptoms including enanthema, exanthema and pruritus. An important gene associated with Skin Conditions is CD247 (CD247 Molecule), and among its related pathways/superpathways are Toll-Like receptor Signaling Pathways and T cell receptor signaling pathway. The drugs Chlorhexidine and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and t cells.

Related Diseases for Skin Conditions

Diseases related to Skin Conditions via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 107)
id Related Disease Score Top Affiliating Genes
1 darier disease 10.4
2 ichthyosis with confetti 10.4
3 nevoid hypermelanosis, linear and whorled 10.4
4 scleredema 10.4
5 crouzon syndrome with acanthosis nigricans 10.4
6 dowling-degos disease 10.4
7 ichthyosis, x-linked 10.3
8 lepromatous leprosy 10.3
9 aquagenic pruritus 10.3
10 morgellons 10.3
11 atypical lichen myxedematosus 10.3
12 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.3
13 erythema nodosum, idiopathic 10.3
14 pigmented purpuric dermatosis 10.3
15 hailey-hailey disease 10.3
16 gianotti crosti syndrome 10.3
17 pityriasis lichenoides 10.3
18 giant congenital nevus 10.3
19 pityriasis lichenoides et varioliformis acuta 10.3
20 erythrokeratodermia variabilis et progressiva 10.3
21 balanitis xerotica obliterans 10.3
22 inverted follicular keratosis 10.3
23 granulomatous rosacea 10.3
24 porokeratosis of mibelli 10.3
25 restrictive dermopathy, lethal 10.3
26 neutrophilic dermatosis, acute febrile 10.3
27 scabies 10.3
28 grover's disease 10.3
29 prurigo nodularis 10.3
30 nail disorder, nonsyndromic congenital, 1 10.3
31 guttate psoriasis 10.3
32 punctate porokeratosis 10.3
33 psoriasis 14, pustular 10.3
34 dermatitis herpetiformis 10.3
35 hydroa vacciniforme 10.3
36 rheumatoid vasculitis 10.3
37 transient bullous of the newborn 10.3
38 ichthyosis linearis circumflexa 10.3
39 erythema multiforme 10.3
40 seborrheic dermatitis 10.3
41 keratosis follicularis spinulosa decalvans 10.3
42 singleton merten syndrome 10.3
43 saddan 10.3
44 congenital generalized lipodystrophy 10.3
45 linear porokeratosis 10.3
46 bullous impetigo 10.3
47 rosacea 10.3
48 localized lipodystrophy 10.3
49 discoid lupus erythematosus 10.3
50 rothmund-thomson syndrome 10.3

Graphical network of the top 20 diseases related to Skin Conditions:



Diseases related to Skin Conditions

Symptoms & Phenotypes for Skin Conditions

UMLS symptoms related to Skin Conditions:


enanthema, exanthema, pruritus, skin manifestations, dry skin, nasal itching

Drugs & Therapeutics for Skin Conditions

Drugs for Skin Conditions (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1101)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 55-56-1 9552079 2713
2
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
3
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 14219 4091
4
Acitretin Approved Phase 4,Phase 3,Phase 2 55079-83-9 6437841 5284513
5
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
6
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
7
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
8
Infliximab Approved Phase 4,Phase 3,Phase 2 170277-31-3
9
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
10
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79217-60-0, 59865-13-3 5284373 6435893
11
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 22916-47-8 4189
12
Ustekinumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 815610-63-0
13
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
14
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 18323-44-9 29029
15
Glycerol Approved, Experimental Phase 4,Phase 1,Phase 2 56-81-5 753
16
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 124-94-7 31307
17
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1 64-17-5 702
18
Phenol Approved, Experimental Phase 4 108-95-2 996
19
Aminolevulinic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 106-60-5 137
20
Isotretinoin Approved Phase 4,Phase 3,Phase 2,Phase 1 4759-48-2 5538 5282379
21
Salicylic acid Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 69-72-7 338
22
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137071-32-0 6447131 17753757
23
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
24
Imiquimod Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 99011-02-6 57469
25
Fexofenadine Approved Phase 4,Phase 2 83799-24-0 3348
26
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 60142-96-3 3446
27
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
28
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2 94-36-0 7187
29
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
30
Hydroquinone Approved Phase 4,Phase 3,Phase 2 123-31-9 785
31
Bosentan Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 147536-97-8 104865
32
Azelaic acid Approved Phase 4,Phase 2,Phase 3,Phase 1 123-99-9 2266
33
Dimethyl fumarate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 624-49-7 637568 5271565
34
Zinc Approved Phase 4,Phase 3,Phase 1,Phase 2 7440-66-6 32051 23994
35
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 112809-51-5 3902
36
Toremifene Approved, Investigational Phase 4,Phase 3,Phase 2 89778-26-7 3005573
37
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33069-62-4 36314
38
Petrolatum Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 8009-03-8
39
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 1 9004-61-9 53477741 24759
40
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Early Phase 1 51-21-8 3385
41
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 159351-69-6 6442177
42
Exemestane Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 107868-30-4 60198
43
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 53123-88-9 5284616 6436030 46835353
44
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 378-44-9 9782
45
Apremilast Approved, Investigational Phase 4,Phase 3,Phase 2 608141-41-9 11561674
46
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 564-25-0 54671203
47
Ivermectin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 70288-86-7 6474909 46936176
48
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
49
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
50
Minoxidil Approved Phase 4,Phase 3,Phase 1,Phase 2 38304-91-5 4201

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 Effect of Chlorhexidine Skin Cleansing on Skin Flora Unknown status NCT00198679 Phase 4
2 Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo Unknown status NCT01333410 Phase 4
3 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Unknown status NCT02438020 Phase 4
4 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4
5 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Unknown status NCT01439425 Phase 4
6 Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy Unknown status NCT01237262 Phase 4
7 Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. Unknown status NCT02248792 Phase 4
8 Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis Unknown status NCT02144857 Phase 4
9 Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate Unknown status NCT02313922 Phase 4
10 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Unknown status NCT01558310 Phase 4
11 Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 Unknown status NCT01443338 Phase 4
12 An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use Unknown status NCT01132235 Phase 4
13 Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis Unknown status NCT00707070 Phase 4
14 Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness Unknown status NCT00150930 Phase 4
15 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4
16 Efficacy & Safety of Clindamycin and Tretinoin in Acne Unknown status NCT01111994 Phase 4
17 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4
18 Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy Unknown status NCT01844141 Phase 4
19 Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Unknown status NCT01491711 Phase 4
20 Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Unknown status NCT01246921 Phase 4
21 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4
22 Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) Unknown status NCT01082393 Phase 4
23 Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus Unknown status NCT01073501 Phase 4
24 Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients Unknown status NCT01538901 Phase 4
25 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Unknown status NCT01656226 Phase 4
26 Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis Unknown status NCT01413763 Phase 4
27 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4
28 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4
29 Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer Unknown status NCT01459666 Phase 4
30 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4
31 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4
32 Clinical Trial of Hydroquinone Versus Miconazol in Melasma Unknown status NCT01661556 Phase 4
33 The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Unknown status NCT02480335 Phase 4
34 Azelaic Acid Versus Hydroquinone in Melasma Unknown status NCT00927771 Phase 4
35 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
36 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4
37 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4
38 Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Unknown status NCT01229319 Phase 4
39 Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene Unknown status NCT01072318 Phase 4
40 Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women Unknown status NCT01069211 Phase 4
41 Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) Unknown status NCT01908556 Phase 4
42 Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia Unknown status NCT01111981 Phase 4
43 A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer Unknown status NCT00912639 Phase 4
44 A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects Completed NCT00731042 Phase 4
45 Fexofenadine in Pruritic Skin Disease Completed NCT00261079 Phase 4
46 Coloplast DialogueStudy Completed NCT00626821 Phase 4
47 Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis Completed NCT00828464 Phase 4
48 Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels Completed NCT00910260 Phase 4
49 A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions Completed NCT02052752 Phase 4
50 Online Question-answering and Conventional Consultation With a Dermatologist Completed NCT01969422 Phase 4

Search NIH Clinical Center for Skin Conditions

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Skin Conditions cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Skin Conditions:
BioDFactor
Stemedyne
Embryonic/Adult Cultured Cells Related to Skin Conditions:
Bone marrow-derived mesenchymal stem cells (Stemedyne PMIDs: 23295150

Genetic Tests for Skin Conditions

Anatomical Context for Skin Conditions

MalaCards organs/tissues related to Skin Conditions:

39
Skin, Bone, T Cells, Kidney, Pancreas

Publications for Skin Conditions

Articles related to Skin Conditions:

(show top 50) (show all 83)
id Title Authors Year
1
Dry skin conditions are related to the recovery rate of skin temperature after cold stress rather than to blood flow. ( 27917468 )
2017
2
Topical pine tar: History, properties and use as a treatment for common skin conditions. ( 26790564 )
2016
3
Spirituality and mood pathology in severe skin conditions: a prospective observational study. ( 27377294 )
2016
4
The epidemiology of skin conditions in the aged: A systematic review. ( 27161662 )
2016
5
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. ( 26686685 )
2016
6
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 27088939 )
2016
7
Parental, child, and adolescent experience of chronic skin conditions: A meta-ethnography and review of the qualitative literature. ( 27768987 )
2016
8
Phototherapy for sclerosing skin conditions. ( 27638441 )
2016
9
Physiological and microbiological verification of the benefit of hair washing in patients with skin conditions of the scalp. ( 27229771 )
2016
10
Is education enough to improve quality of life in people with chronic inflammatory skin conditions? ( 27317274 )
2016
11
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 26858051 )
2016
12
Inflammatory Skin Conditions Associated With Radiotherapy. ( 28010872 )
2016
13
Occupational Skin Conditions in the Emerging US Green Collar Workforce. ( 27172317 )
2016
14
Data on medicinal plants used in Central America to manage diabetes and its sequelae (skin conditions, cardiovascular disease, kidney disease, urinary problems and vision loss). ( 27761504 )
2016
15
Surgical Reconstruction of Traumatic Partial Ear Defects Based on a Novel Classification of Defect Sizes and Surrounding Skin Conditions. ( 27465192 )
2016
16
Skin conditions in children. ( 27180500 )
2016
17
Treating skin conditions in the community: know your emollients. ( 27594060 )
2016
18
Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged. ( 27544020 )
2016
19
Skin conditions in a South African tuberculosis hospital: Prevalence, description, and possible associations. ( 27419379 )
2016
20
Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence. ( 26833102 )
2016
21
Six years' experience of grenz ray therapy for the treatment of inflammatory skin conditions. ( 27747909 )
2016
22
Implicit stigmatization-related biases in individuals with skin conditions and their significant others. ( 27505208 )
2016
23
Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review. ( 27367679 )
2016
24
Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial. ( 26581682 )
2016
25
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. ( 26994263 )
2016
26
Laser treatment of periocular skin conditions. ( 25704939 )
2015
27
Alexithymia, dissociation, and trauma in patients with chronic skin conditions. ( 26159657 )
2015
28
Ingestion of hyaluronans (molecular weights 800 k and 300 k) improves dry skin conditions: a randomized, double blind, controlled study. ( 25834304 )
2015
29
Dermatology for the pediatrician: Advances in diagnosis and treatment of common and not-so-common skin conditions. ( 26555809 )
2015
30
Effects of Orally Administered Pyrroloquinoline Quinone Disodium Salt on Dry Skin Conditions in Mice and Healthy Female Subjects. ( 26226961 )
2015
31
A glossary of terms to assist the recognition and diagnosis of skin conditions associated with lower-limb chronic oedema. ( 25950393 )
2015
32
Working together to manage common skin conditions. ( 26618674 )
2015
33
Health-Related Quality of Life in Chronic Pruritus: An Analysis Related to Disease Etiology, Clinical Skin Conditions and Itch Intensity. ( 26278551 )
2015
34
Angioma serpiginosum: report of two cases suggesting type 1 mosaicism and proposal of adding it to the list of mosaic skin conditions. ( 25711206 )
2015
35
Teledermatologists' management of emergency skin conditions. ( 26424060 )
2015
36
Occlusive gloves and skin conditions: is there a problem? Results of a cross-sectional study in a semiconductor company. ( 25319754 )
2015
37
Elastin hydrolysate derived from fish enhances proliferation of human skin fibroblasts and elastin synthesis in human skin fibroblasts and improves the skin conditions. ( 25996804 )
2015
38
Relationship Between Psychosocial Burden of Skin Conditions and Symptoms: Measuring the Attributable Fraction. ( 25766753 )
2015
39
Preventing and treating peristomal skin conditions in stoma patients. ( 26252235 )
2015
40
A review of skin conditions in modern warfare and peacekeeping operations. ( 25562855 )
2015
41
EQ-5D in skin conditions: an assessment of validity and responsiveness. ( 25358263 )
2014
42
Follicular mucinosis associated with nonlymphoid skin conditions. ( 25072678 )
2014
43
Skin conditions in primary care: an analysis of referral demand. ( 24657024 )
2014
44
Topical photodynamic therapy for non-malignant skin conditions: experience from a university teaching hospital. ( 24517855 )
2014
45
Infective skin conditions in an adult sea-going population. ( 24881427 )
2014
46
Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. ( 25218434 )
2014
47
Idiopathic hypereosinophilic syndrome with multiple organ infarction: improvement of the skin condition masking the course of disease. ( 24667633 )
2014
48
Tattoos and coincidental skin conditions: the example of lymphomatoid papulosis. ( 24841722 )
2014
49
Association between skin conditions and depressive disorders in community-dwelling older adults. ( 25008442 )
2014
50
Retraction. Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. ( 24971365 )
2014

Variations for Skin Conditions

Expression for Skin Conditions

Search GEO for disease gene expression data for Skin Conditions.

Pathways for Skin Conditions

GO Terms for Skin Conditions

Cellular components related to Skin Conditions according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.17 DCD IFNK IGFL1 IGFL2 IGFL3 IL1A

Biological processes related to Skin Conditions according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 humoral immune response GO:0006959 9.26 IFNK TNF
2 positive regulation of interleukin-6 production GO:0032755 9.16 IL1A TNF
3 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 8.96 IL1A TNF
4 positive regulation of cytokine secretion GO:0050715 8.62 IL1A TNF

Molecular functions related to Skin Conditions according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNK IL1A TNF

Sources for Skin Conditions

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....